MD SB748

Maryland Department of Health must incorporate FDA-approved Alzheimer's disease and related dementias treatments into public health outreach programs, partnering with the Department of Aging, Virginia I. Jones Alzheimer's Disease and Related Dementias Council, and Greater Maryland Chapter of the Alzheimer's Association

Healthcare provider education expanded to include information on FDA-approved treatments, treatment use, and outcomes for Alzheimer's and related dementias

Public awareness outreach must address treatment options and outcomes, including information on treatment outcomes based on biological sex, with focus on Black and Latino communities at higher risk

Department must establish a publicly accessible website with downloadable data on Alzheimer's prevalence and hospitalization rates, disaggregated by age, sex, race, ethnicity, county, co-occurrence of Down syndrome, and dementia type

Website must include data for the 5-year period ending September 30, 2025, with annual updates beginning January 1, 2027; effective date October 1, 2025